Načítá se...
Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells
BACKGROUND: Autologous and allogeneic adult mesenchymal stem/stromal cells (MSCs) are increasingly being investigated for treating a wide range of clinical diseases. Allogeneic MSCs are especially attractive due to their potential to provide immediate care at the time of tissue injury or disease dia...
Uloženo v:
| Vydáno v: | Stem Cell Res Ther |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5741939/ https://ncbi.nlm.nih.gov/pubmed/29273086 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-017-0742-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|